Mori Memorial Foundation Issues GPCI–2023 & GPCI–Financial Centers Reports
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban developer, announced today its Global Power City Index (GPCI) 2023 report on the overall strength of the world’s 48 major cities. There was no change in the rankings from 1st to 7th, and Tokyo (3rd) and Paris (4th) remained close, neither managing to grow their scores from last year. Among other top 10 cities, Dubai rose from 11th to 8th, becoming the first Middle Eastern city in the top 10, while Shanghai dropped from 10th to 15th and Berlin fell two places to 10th. London (1st) and Singapore (5th) improved their scores by renewing strengths that had stagnated during the pandemic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231108660329/en/
48 major cities evaluated in Mori Memorial Foundation’s GPCI–2023 Report (Graphic: Business Wire)
Global conditions such as international conflicts, high inflation and changing workstyles had a significant impact on this year’s rankings overall as well as in six urban functions and 70 indicators. In many cities, “Number of Air Passengers” and “Number of Arrivals and Departures at Airports” under the Accessibility function remained below 2019 levels, indicating continued stagnation in the international aviation sector.
In Livability, “Price Level” and “Housing Rent“ rankings changed significantly, likely due to the cost of living. Scores generally declined in “Number of Retail Stores” and “Number of Restaurants,” especially among U.S. cities, suggesting that recent work-from-home trends as well as cost of living continued to impact city centers. In Accessibility, “Commuting Time” continued to decrease in the majority of cities since 2019 based on data collected through residential surveys in each city.
Looking at each of the six functions, starting with Economy, Tokyo lost much of its strength and dropped five places to 10th, mainly due to less competitiveness in “Variety of Workplace Options” and “Wage Levels.” In R&D, continued strength was exhibited by New York and other U.S. cities that made up half of the top 10. London showed overwhelming strength in Cultural Interaction, especially with recovered performance in “Number of Foreign Visitors,” and Dubai also expanded its presence in this function. Livability saw the most change due to rising costs of living. In Environment, European cities, especially those with populations under one million, continued to dominate the top ranks, as they did last year. Strong “Commitment to Climate Action” influenced rankings, as in the case of Geneva, which gained significant strength in this indicator. In Accessibility, Amsterdam was No. 1 for the first time due to high scores in “Commuting Time” and “Average Driving Speed,” whereas in previous years the top cities tended to score well in “Number of Air Passengers” and “Direct International Flights.”
GPCI–2023 Highlights
London (1st)
London, after seeing its scores decline during the pandemic, made a strong comeback this year in indicators such as “Wage Level” (Economy), “Number of Foreign Visitors” (Cultural Interaction) and “Number of Air Passengers” (Accessibility), all of which rose from last year. Even after the pandemic, London's international air connections remained strong. Scores that declined, however, included “Availability of Skilled Human Resources” (Economy), “Satisfaction with Urban Cleanliness” (Environment) and “Average Driving Speed” (Accessibility).
New York (2nd)
New York remained in 2nd, but its overall score lost ground to London. The city improved in “Wage Level,” “Variety of Workplace Options” and “Commuting Time” (Economy) but declined in “Number of Retail Shops” and “Number of Restaurants” (Livability). Reflecting concerns about the hollowing out of cities due to changes in workstyles, New York lost competitiveness in its number of restaurants and retail stores, representative features of urban life.
Tokyo (3rd)
Tokyo held on to 3rd but was still close to Paris in 4th. “Price Level” and “Housing Rent” (Livability) both improved due to the impact of a weaker yen, which strengthened Tokyo’s position as a more affordable city to live in. However, Tokyo lost competitiveness in “Wage Level” and “Variety of Workplace Options” to fall to 10th in Economy, its lowest ranking ever in this function. Tokyo also slipped in “Commitment to Climate Action” and “Satisfaction with Urban Cleanliness” (Environment).
Paris (4th)
Paris came within striking distance of third-place Tokyo but was unable to reverse the ranking. In Accessibility, Paris improved in “Number of Air Passengers” but weakened in “Average Driving Speed” and “Ease of Mobility by Taxi or Bicycle,” both measures of intra-city mobility, in contrast to Amsterdam, which rose in both indicators. Improving intra-city mobility will be key to Paris’ future prospects as it prepares to host the 2024 Summer Olympic Games.
Singapore (5th)
Singapore, like London, regained strength after stagnating since the start of the pandemic in 2020. This year the city scored higher in “Wage Level” (Economy), “Number of Foreign Visitors” (Cultural Interaction) and “Number of Air Passengers” (Accessibility). However, while the soaring cost of living was pronounced among all cities, Singapore suffered a particularly significant drop from 25th to 35th in Livability, including lower scores in both “Housing Rent” and “Price Level.”
Dubai (8th)
Dubai rose to 8th, its highest ranking ever, thanks to improved scores in Economy, Cultural Interaction, Livability and Accessibility. In Economy, it ranked 1st in “Corporate Tax Rate” and rose from 23rd to 10th in “Wage Level.” In Cultural Interaction, it was 1st in “Number of Foreign Residents” and 2nd in “Number of Luxury Hotel Rooms.” It also was 1st in “Total Unemployment Rate” and “Workstyle Flexibility” (Livability) as well as “Average Driving Speed” (Accessibility). Dubai is steadily increasing its presence as a core city in the Middle East, similar to London in Europe and New York in the Americas.
Shanghai (15th)
Shanghai suffered a precipitous fall from the top 10, dropping to 15th. In Accessibility, Shanghai dropped from 1st to 9th. Worse, due to China’s prolonged travel restrictions, the city plunged from 3rd to 27th in “Number of Air Passengers.” It also fell in “Average Driving Speed” and “Ease of Mobility by Taxi or Bicycle,” indicating that improvements are needed not only in international connections but also the ease and convenience of traveling within Shanghai.
GPCI–Financial Centers
The rapid expansion and internationalization of the global financial industry is intensifying competition among major cities, making each city’s status as an international financial center increasingly important. The Mori Memorial Foundation, in addition to its multifaceted evaluation of cities in terms of six functions in the Global Power City Index (GPCI), namely Economy, R&D, Cultural Interaction, Livability, Environment, and Accessibility, has now added the Finance function, which consists of 14 indicators in 4 groups.
The global financial sector is led by New York and London, followed by four Asian cities: Tokyo, Beijing, Shanghai, and Hong Kong. The financial characteristics of these top cities are described below.
- New York: Highly ranked in all four groups of indicators, and first in four specific indicators: “Stock Market Capitalization,” “Stock Market Trading Value,” “World’s Top Asset Managers,” and “International Law Offices.”
- London: Ranked first in both “Foreign Exchange Turnover” and “Interest Rate Derivatives Turnover,” indications of the city’s distinctive strengths. Also ranked second in “Highly Skilled Personnel.”
- Tokyo: Strong in Financial Intermediaries, ranking first in the indicators “World’s Top Insurance Company Headquarters” and “World’s Top Pension Funds.”
- Beijing: Strong in Financial Intermediaries and Highly Skilled Personnel, including ranking first in “World’s Top Bank Headquarters.”
- Shanghai: Strong in Financial Instruments Markets, ranking first in “Capital Raised Through IPOs,” second in “Stock Market Capitalization,” and third in “Stock Market Trading Value.”
- Hong Kong: Strong in Foreign Exchange and Interest Rate Markets (3rd), Highly Skilled Personnel (4th) and Financial Instruments Markets (5th).
The full press release can be viewed at the following link:
https://mori-m-foundation.or.jp/pdf/GPCI2023_release_en.pdf
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231108660329/en/
Contact information
Hiromi Jimbo and Peter Dustan, Institute for Urban Strategies, The Mori Memorial Foundation
+81 (0)3-6406-6800
iusall@mori-m-foundation.or.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 15:00:00 EEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall deep and durable responses across the frontline CLL patient spectrum, including patients with high-risk mutational status. The best undetectable minimal residual disease (uMRD) rate in peripheral blood at a sensitivity level 10-4 was 59%. These efficacy responses observed in Arm D, despite the high proportion of high-risk patients enrolled, are in
You Up? Grindr’s “Right Now” Goes Global30.5.2025 16:00:00 EEST | Press release
Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded people without wasting time on mismatched expectations. The response to our initial March launc
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 15:00:00 EEST | Press release
Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. “Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,” said Miguel Perale
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 12:17:00 EEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
FDA Grants De Novo Clearance for Reflow Medical's Spur ® Peripheral Retrievable Stent System30.5.2025 07:08:00 EEST | Press release
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom